Post by
1rockit on Aug 16, 2021 5:30pm
$$ ;
Just trying to work out which RHT is more closely aligned.. Should we compare it to the dot.com era where the stocks went ballistic or should we compare it to the pot stock craze of just a very few years ago , close enough in time where most people can reflect . Me , I think it's like a little combination of both . Cheers everyone, I think we're all going to make a pile of money !!
Comment by
azzypayyan on Aug 16, 2021 7:41pm
So assuming they reach their run rate of $2m per month by end of year, what does that translate into for the share price with the current number of outstanidng shares?
Comment by
lscfa on Aug 17, 2021 2:27am
Price to sales multiples are lousy valuation tools because some revenues are more profitable than others. The revenue multiples on pre-earnings companies are always euphoric but come down to earth when profits start. I don't care what kind of company it is once cash flow is being generated. Cash is cash.
Comment by
lscfa on Aug 17, 2021 9:00am
PI Financial used a ebitda multiple of 12x in 2018 when Reliq was boasting about onboarding 10's of thousands of patients. https://themoneynarrative.files.wordpress.com/2018/06/pi-financial-rht-v-initial-report-june-26-2018.pdf
Comment by
azzypayyan on Aug 17, 2021 1:03pm
This is just my guess but I think the July-Sep quarter will show better than expected progress, which should drive the stock much higher. Lisa has said that the company's guidance was based on existing contracts. They've added a lot of other contracts since then and have, apparently, began onboarding. If all of that is true, the quarterlies should be a nice surprise.
Comment by
watch22 on Aug 17, 2021 1:52pm
sorry... that should actually show 125,000 onboarded patients for 2023... just the same run-rate as Q4